BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 31582847)

  • 1. Bromodomain biology and drug discovery.
    Zaware N; Zhou MM
    Nat Struct Mol Biol; 2019 Oct; 26(10):870-879. PubMed ID: 31582847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bromodomain: from epigenome reader to druggable target.
    Sanchez R; Meslamani J; Zhou MM
    Biochim Biophys Acta; 2014 Aug; 1839(8):676-85. PubMed ID: 24686119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting non-bromodomain chromatin readers.
    Arrowsmith CH; Schapira M
    Nat Struct Mol Biol; 2019 Oct; 26(10):863-869. PubMed ID: 31582844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research progress of selective small molecule bromodomain-containing protein 9 inhibitors.
    Hui M; Jian Z; Peiyuan Z; Zhenwei W; Huibin Z
    Future Med Chem; 2018 Apr; 10(8):895-906. PubMed ID: 29620420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting epigenetic reader domains by chemical biology.
    Cipriano A; Sbardella G; Ciulli A
    Curr Opin Chem Biol; 2020 Aug; 57():82-94. PubMed ID: 32739717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BET Bromodomain as a Target of Epigenetic Therapy.
    Noguchi-Yachide T
    Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging tools to investigate bromodomain functions.
    Kougnassoukou Tchara PE; Filippakopoulos P; Lambert JP
    Methods; 2020 Dec; 184():40-52. PubMed ID: 31726225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodomains: Structure, function and pharmacology of inhibition.
    Ferri E; Petosa C; McKenna CE
    Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromodomain inhibitors and cancer therapy: From structures to applications.
    PĂ©rez-Salvia M; Esteller M
    Epigenetics; 2017 May; 12(5):323-339. PubMed ID: 27911230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Molecules Targeting the Specific Domains of Histone-Mark Readers in Cancer Therapy.
    Zhu H; Wei T; Cai Y; Jin J
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay.
    Lu T; Hu JC; Lu WC; Han J; Ding H; Jiang H; Zhang YY; Yue LY; Chen SJ; Jiang HL; Chen KX; Chai HF; Luo C
    Acta Pharmacol Sin; 2018 Sep; 39(9):1544-1552. PubMed ID: 29795359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domain cross-talk in regulation of histone modifications: Molecular mechanisms and targeting opportunities.
    Longbotham JE; Zhang MY; Fujimori DG
    Curr Opin Chem Biol; 2020 Aug; 57():105-113. PubMed ID: 32758979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates.
    Furdas SD; Kannan S; Sippl W; Jung M
    Arch Pharm (Weinheim); 2012 Jan; 345(1):7-21. PubMed ID: 22234972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying the Selectivity of Protein-Protein and Small Molecule Interactions with Fluorinated Tandem Bromodomain Reader Proteins.
    Kalra P; McGraw L; Kimbrough JR; Pandey AK; Solberg J; Cui H; Divakaran A; John K; Hawkinson JE; Pomerantz WCK
    ACS Chem Biol; 2020 Nov; 15(11):3038-3049. PubMed ID: 33138352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomains and their pharmacological inhibitors.
    Gallenkamp D; Gelato KA; Haendler B; Weinmann H
    ChemMedChem; 2014 Mar; 9(3):438-64. PubMed ID: 24497428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation.
    Zaware N; Zhou MM
    Curr Opin Chem Biol; 2017 Aug; 39():116-125. PubMed ID: 28689146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer.
    Verma SK; Knight SD
    Future Med Chem; 2013 Sep; 5(14):1661-70. PubMed ID: 24047271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
    Taniguchi Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of human bromodomains in chromatin biology and gene transcription.
    Sanchez R; Zhou MM
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):659-65. PubMed ID: 19736624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.